Cited by 376Hormonal Regulation and HypertensionRenin-Angiotensin System StudiesAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis

Huby, Anne-Cécile, Antonova, Galina, Groenendyk, Jake, Gomez-Sanchez, Celso E., Bollag, Wendy B., Filosa, Jessica A., de Chantemèle, Eric J. Belin·2015·Circulation

DOI 10.1161/circulationaha.115.018226

Open this paper in CoChat — free account

Abstract

BACKGROUND: In obesity, the excessive synthesis of aldosterone contributes to the development and progression of metabolic and cardiovascular dysfunctions. Obesity-induced hyperaldosteronism is independent of the known regulators of aldosterone secretion, but reliant on unidentified adipocyte-derived factors. We hypothesized that the adipokine leptin is a direct regulator of aldosterone synthase (CYP11B2) expression and aldosterone release and promotes cardiovascular dysfunction via aldosterone-dependent mechanisms. METHODS AND RESULTS: Immunostaining of human adrenal cross-sections and adrenocortical cells revealed that adrenocortical cells coexpress CYP11B2 and leptin receptors. Measurements of adrenal CYP11B2 expression and plasma aldosterone levels showed that increases in endogenous (obesity) or exogenous (infusion) leptin dose-dependently raised CYP11B2 expression and aldosterone without elevating plasma angiotensin II, potassium or corticosterone. Neither angiotensin II receptors blockade nor α and β adrenergic receptors inhibition blunted leptin-induced aldosterone secretion. Identical results were obtained in cultured adrenocortical cells. Enhanced leptin signaling elevated CYP11B2 expression and plasma aldosterone, whereas deficiency in leptin or leptin receptors blunted obesity-induced increases in CYP11B2 and aldosterone, ruling out a role for obesity per se. Leptin increased intracellular calcium, elevated calmodulin and calmodulin-kinase II expression, whereas calcium chelation blunted leptin-mediated increases in CYP11B2, in adrenocortical cells. Mineralocorticoid receptor blockade blunted leptin-induced endothelial dysfunction and increases in cardiac fibrotic markers. CONCLUSIONS: Leptin is a newly described regulator of aldosterone synthesis that acts directly on adrenal glomerulosa cells to increase CYP11B2 expression and enhance aldosterone production via calcium-dependent mechanisms. Furthermore, leptin-mediated aldosterone secretion contributes to cardiovascular disease by promoting endothelial dysfunction and the expression of profibrotic markers in the heart.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.115.018226

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

PTP1B Regulates Leptin Signal Transduction In Vivo
Zabolotny, J. M., Bence, K. K., Stricker‐Krongrad, A., Haj, F. G., Wang, Y., Minokoshi, Y., Kim, Y., Elmquist, J. K., Tartaglia, L. A., Kahn, B. B., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00148-x · Cited by 818
Human Leptin Deficiency Caused by a Missense Mutation: Multiple Endocrine Defects, Decreased Sympathetic Tone, and Immune System Dysfunction Indicate New Targets for Leptin Action, Greater Central than Peripheral Resistance to the Effects of Leptin, and Spontaneous Correction of Leptin-Mediated Defects
Ozata, M., Ozdemir, I. C., & Licinio, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.5999 · Cited by 739
Cardiac remodeling in obesity
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736
Attenuation of Leptin Action and Regulation of Obesity by Protein Tyrosine Phosphatase 1B
Cheng, A., Uetani, N., Simoncic, P. D., Chaubey, V. P., Lee-Loy, A., McGlade, C. J., Kennedy, B. P., & Tremblay, M. L. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00149-1 · Cited by 545
Obesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins
Hall, J. E., da Silva, A. A., do Carmo, J. M., Dubinion, J., Hamza, S., Munusamy, S., Smith, G., & Stec, D. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.113175 · Cited by 528
Control of aldosterone secretion: a model for convergence in cellular signaling pathways
SPÄT, A., & HUNYADY, L. (2004) · Physiological Reviews · doi:10.1152/physrev.00030.2003 · Cited by 494
Human adipocytes secrete mineralocorticoid-releasing factors
Ehrhart‐Bornstein, M., Lamounier‐Zepter, V., Schraven, A., Langenbach, J., Willenberg, H. S., Barthel, A., Hauner, H., McCann, S. M., Scherbaum, W. A., & Bornstein, S. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336140100 · Cited by 442
Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction
Briones, A. M., Nguyen Dinh Cat, A., Callera, G. E., Yogi, A., Burger, D., He, Y., Corrêa, J. W., Gagnon, A. M., Gomez-Sanchez, C. E., Gomez-Sanchez, E. P., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.190223 · Cited by 375
Sixteen years and counting: an update on leptin in energy balance
Gautron, L., & Elmquist, J. K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45888 · Cited by 367
Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension
Sowers, J. R., Whaley-Connell, A., & Epstein, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00005 · Cited by 351

Flagged first, then by citations

Show all 49 references

Research works printed but not linked: 2

10.1161/01.HYP.0000231338.41548.fc · DOI · Paper page
10.1161/01.HYP.0000253258.36141.c7 · DOI

Sorted by citations

Items 101–200 of 374

Leptin Restores Endothelial Function via Endothelial PPARγ-Nox1–Mediated Mechanisms in a Mouse Model of Congenital Generalized Lipodystrophy
Bruder-Nascimento, T. B., Faulkner, J., Haigh, S. B., Kennard, S., Antonova, G. N., Patel, V. S., Fulton, D. J., Chen, W., & de Chantemèle, E. J. B. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13398 · Cited by 36
Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists
Mende, C. W., Samarakoon, R., & Higgins, P. J. (2023) · American Journal of Nephrology · doi:10.1159/000528783 · Cited by 37
Hypertension Due to Toxic White Crystals in the Diet: Should We Blame Salt or Sugar?
DiNicolantonio, J. J., & O’Keefe, J. H. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.07.004 · Cited by 36
HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor‐Dependent Increases in NADPH Oxidase 1 (Nox1), C‐C Chemokine Receptor Type 5 (CCR5), and Inflammation
Bruder-Nascimento, T. B., Kress, T. C., Kennard, S., & de Chantemèle, E. J. B. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018074 · Cited by 36
Very low-density lipoprotein (VLDL)-induced signals mediating aldosterone production
Tsai, Y.-Y., Rainey, W. E., & Bollag, W. B. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0237 · Cited by 37
Vascular Mineralocorticoid Receptor: Evolutionary Mediator of Wound Healing Turned Harmful by Our Modern Lifestyle
Biwer, L. A., Wallingford, M. C., & Jaffe, I. Z. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy158 · Cited by 35
Cardiometabolic Traits and Systolic Mechanics in the Community
Ho, J. E., McCabe, E. L., Wang, T. J., Larson, M. G., Levy, D. A., Tsao, C. W., Aragam, J. R., Mitchell, G. F., Benjamin, E. J., Vasan, R. S., et al. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003536 · Cited by 35
Contribution of Maladaptive Adipose Tissue Expansion to Development of Cardiovascular Disease
Jia, G., Jia, Y., & Sowers, J. R. (2016) · Comprehensive physiology · doi:10.1002/cphy.c160014 · Cited by 38
Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease
Gorini, S., Marzolla, V., Mammi, C., Armani, A., & Caprio, M. (2018) · Biomolecules · doi:10.3390/biom8030096 · Cited by 36
Aldosterone breakthrough from a pharmacological perspective
Mogi, M. (2022) · Hypertension Research · doi:10.1038/s41440-022-00913-4 · Cited by 32
Vascular endothelial mineralocorticoid receptors and epithelial sodium channels in metabolic syndrome and related cardiovascular disease
Jia, G., Hill, M. A., & Sowers, J. R. (2023) · Journal of Molecular Endocrinology · doi:10.1530/jme-23-0066 · Cited by 32
Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population
Shemisa, K., Bhatt, A. B., Cheeran, D. D., & Neeland, I. J. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0342-z · Cited by 32
Relationship Between Visceral Fat and Plasma Aldosterone Concentration in Patients With Primary Aldosteronism
Shibayama, Y., Wada, N., Baba, S., Miyano, Y., Obara, S., Iwasaki, R., Nakajima, H., Sakai, H., Usubuchi, H., Terae, S., et al. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00187 · Cited by 32
Clinical Evidence and Proposed Mechanisms of Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Class Effect?
Deschaine, B., Verma, S., & Rayatzadeh, H. (2022) · Cardiac failure review · doi:10.15420/cfr.2022.11 · Cited by 34
Midgestation Leptin Infusion Induces Characteristics of Clinical Preeclampsia in Mice, Which Is Ablated by Endothelial Mineralocorticoid Receptor Deletion
Faulkner, J., Wright, D., Antonova, G. N., Jaffe, I. Z., Kennard, S., & de Chantemèle, E. J. B. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.18832 · Cited by 31
Mineralocorticoid Receptor and Endothelial Dysfunction in Hypertension
Faulkner, J., & de Chantemèle, E. J. B. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0981-4 · Cited by 32
The association between weight-adjusted waist circumference index and cardiovascular disease and mortality in patients with diabetes
Tao, Z., Zuo, P., & Ma, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-69712-w · Cited by 30
Adipose tissue insulin resistance predicts the incidence of hypertension: The Hiroshima Study on Glucose Metabolism and Cardiovascular Diseases
Sasaki, N., Maeda, R., Ozono, R., Yoshimura, K., Nakano, Y., & Higashi, Y. (2022) · Hypertension Research · doi:10.1038/s41440-022-00987-0 · Cited by 33
Aldosterone in vascular and metabolic dysfunction
Luther, J. M. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000189 · Cited by 30
Leptin and Aldosterone
Faulkner, J., & de Chantemèle, E. J. B. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.09.003 · Cited by 30
Paracrine Regulation of Aldosterone Secretion in Physiological and Pathophysiological Conditions
Lefèbvre, H., Duparc, C., Naccache, A., Lopez, A.-G., Castanet, M., & Louiset, E. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.10.001 · Cited by 29
Mineralocorticoid Receptor Blockade with Finerenone Improves Heart Function and Exercise Capacity in Ovariectomized Mice
Pieronne-Deperrois, M., Gueret, A., Djerada, Z., Crochemore, C., Harouki, N., Henry, J., Dumesnil, A., Larchevêque, M., do-Rego, J.-C., do Rego, J. L., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13219 · Cited by 29
GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review
Jarade, C., Zolotarova, T., Moiz, A., & Eisenberg, M. J. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102789 · Cited by 31
Primary Aldosteronism and Obstructive Sleep Apnea: Casual Association or Pathophysiological Link?
Pecori, A., Buffolo, F., Pieroni, J., Forestiero, V., Sconfienza, E., Veglio, F., Mulatero, P., & Monticone, S. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1133-7255 · Cited by 28
Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway
Nonn, O., Fischer, C., Geisberger, S., Heliebi, A. E., Kroneis, T., Forstner, D., Desoyé, G., Staff, A. C., Sugulle, M., Dechend, R., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16425 · Cited by 29
Adipokines: Deciphering the cardiovascular signature of adipose tissue
Galley, J. C., Singh, S., Awata, W. M. C., Alves, J. V., & Bruder-Nascimento, T. B. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115324 · Cited by 32
Challenges and opportunities in obesity: the role of adipocytes during tissue fibrosis
Zhang, Q., Lu, C., Lu, F., Liao, Y., Cai, J., & Gao, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1365156 · Cited by 28
Regulation of Aldosterone Secretion
MacKenzie, S. M., van Kralingen, J. C., & Davies, E. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.07.001 · Cited by 32
Vascular and hormonal interactions in the adrenal gland
Abdellatif, A. B., Fernandes-Rosa, F. L., Boulkroun, S., & Zennaro, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.995228 · Cited by 26
Fasting Therapy Contributes to the Improvement of Endothelial Function and Decline in Vascular Injury‐Related Markers in Overweight and Obese Individuals via Activating Autophagy of Endothelial Progenitor Cells
Sun, J., Zhang, T., Zhang, L., Ke, B., & Qin, J. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/3576030 · Cited by 27
Implications of pregnancy on cardiometabolic disease risk: preeclampsia and gestational diabetes
Elgazzaz, M., Woodham, P. C., Maher, J. E., & Faulkner, J. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00293.2024 · Cited by 26
Resistin is a prognostic factor for death in type 2 diabetes
Kapłon‐Cieślicka, A., Tymińska, A., Rosiak, M., Ozierański, K., Peller, M., Eyileten, C., Kondracka, A., Pordzik, J., Mirowska-Guzel, D. M., Opolski, G., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3098 · Cited by 25
Obesity and the dysregulation of fatty acid metabolism: implications for healthy aging
Morgan, A. E., Mooney, K. M., & Auley, M. T. M. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1245141 · Cited by 24
Sex Differences in Leptin Control of Cardiovascular Function in Health and Metabolic Diseases
de Chantemèle, E. J. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_6 · Cited by 27
Salt sensitivity of blood pressure: mechanisms and sex-specific differences
Masenga, S. K., Wandira, N., Cattivelli-Murdoch, G., Saleem, M., Beasley, H. K., Hinton, A. O., Jr., Ertuğlu, L. A., Mwesigwa, N., Kleyman, T. R., & Kirabo, A. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01135-0 · Cited by 28
Aldosterone: Essential for Life but Damaging to the Vascular Endothelium
Crompton, M., Skinner, L. J., Satchell, S. C., & Butler, M. J. (2023) · Biomolecules · doi:10.3390/biom13061004 · Cited by 26
Association between the weight-adjusted waist index and the odds of type 2 diabetes mellitus in United States adults: a cross-sectional study
Zheng, D., Zhao, S., Luo, D., Lu, F., Ruan, Z., Dong, X., & Chen, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1325454 · Cited by 24
The Association of Life’s Simple 7 with Aldosterone among African Americans in the Jackson Heart Study
Kesireddy, V., Tan, Y., Kline, D., Brock, G. N., Odei, J. B., Kluwe, B., Effoe, V. S., Echouffo-Tcheugui, J. B., Kalyani, R. R., Sims, M., et al. (2019) · Nutrients · doi:10.3390/nu11050955 · Cited by 23
Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function
Bruder-Nascimento, T. B., Kress, T. C., & de Chantemèle, E. J. B. (2019) · F1000Research · doi:10.12688/f1000research.20150.1 · Cited by 23
Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division
Vecchiola, A., Fuentes, C., Solar, I., Lagos, C. F., Opazo, M. C., Muñoz‐Durango, N., Riedel, C. A., Owen, G. I., Kalergis, A. M., & Fardella, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00223 · Cited by 23
Role of Rho in Salt-Sensitive Hypertension
Kawarazaki, W., & Fujita, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062958 · Cited by 23
Mineralocorticoid and Estrogen Receptors in Endothelial Cells Coordinately Regulate Microvascular Function in Obese Female Mice
Biwer, L. A., Carvajal, B. V., Lu, Q. R., Man, J. J., & Jaffe, I. Z. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16911 · Cited by 24
Steroid Metabolomic Signature of Insulin Resistance in Childhood Obesity
Gawlik, A., Shmoish, M., Hartmann, M. F., Wudy, S. A., & Hochberg, Z. (2019) · Diabetes Care · doi:10.2337/dc19-1189 · Cited by 23
Minor role of mature adipocyte mineralocorticoid receptor in high-fat diet-induced obesity
Feraco, A., Armani, A., Urbanet, R., Cat, A. N. D., Marzolla, V., Jaisser, F., & Caprio, M. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0314 · Cited by 22
The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects
Spyroglou, A., Handgriff, L., Müller, L., Schwarzlmueller, P., Parasiliti‐Caprino, M., Fuß, C. T., Remde, H., Hirsch, A., O’Toole, S. M., Thuzar, M., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0040 · Cited by 22
Selective deficiency in endothelial PTP1B protects from diabetes and endoplasmic reticulum stress-associated endothelial dysfunction via preventing endothelial cell apoptosis
Legeay, S., Fautrat, P., Norman, J. B., Antonova, G. N., Kennard, S., Bruder-Nascimento, T. B., Patel, V. S., Faure, S., & de Chantemèle, E. J. B. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110200 · Cited by 22
Pericardial Adipose Tissue–Derived Leptin Promotes Myocardial Apoptosis in High‐Fat Diet–Induced Obese Rats Through Janus Kinase 2/Reactive Oxygen Species/Na+/K+‐ATPase Signaling Pathway
Wang, P., Luo, C., Zhu, D., Song, Y., Cao, L., Luan, H., Gao, L., Zheng, S., Li, H., & Tian, G. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021369 · Cited by 22
Effects of astaxanthin supplementation in healthy and obese dogs
Murai, T., Kawasumi, K., Tominaga, K., Okada, Y., Kobayashi, M., & Arai, T. (2019) · Veterinary Medicine Research and Reports · doi:10.2147/vmrr.s186202 · Cited by 21
Adipocyte-Mineralocorticoid Receptor Alters Mitochondrial Quality Control Leading to Mitochondrial Dysfunction and Senescence of Visceral Adipose Tissue
Lefranc, C., Friederich‐Persson, M., Foufelle, F., Cat, A. N. D., & Jaisser, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062881 · Cited by 20
Chronic Exposure to HIV-Derived Protein Tat Impairs Endothelial Function via Indirect Alteration in Fat Mass and Nox1-Mediated Mechanisms in Mice
Kovács, L., Bruder-Nascimento, T. B., Greene, L., Kennard, S., & de Chantemèle, E. J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010977 · Cited by 20
Obesity-related heart failure with preserved ejection fraction: diagnostic and therapeutic challenges
Jung, M., & Shin, M. (2023) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.271 · Cited by 23
Aldosterone induces renal fibrosis by promoting HDAC1 expression, deacetylating H3K9 and inhibiting klotho transcription
Lai, L., Cheng, P., Yan, M., Gu, Y., & Xue, J. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9781 · Cited by 20
Adipocyte Mineralocorticoid Receptor
Infante, M., Armani, A., Marzolla, V., Fabbri, A., & Caprio, M. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.10.005 · Cited by 20
The Aldosterone/Renin Ratio Predicts Cardiometabolic Disorders in Subjects Without Classic Primary Aldosteronism
Vecchiola, A., Fuentes, C., Barros, E., Martínez‐Aguayo, A., García, H., Allende, F. A., Solari, S., Olmos, R. I., Carvajal, C. A., Tapia-Castillo, A., et al. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz023 · Cited by 20
PDGFRb+ mesenchymal cells, but not NG2+ mural cells, contribute to cardiac fat
Jiang, Z., Feng, T., Lu, Z., Wei, Y., Meng, J., Lin, C., Zhou, B., Liu, C., & Zhang, H. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108697 · Cited by 19
Obesity and Heart Failure with Preserved Ejection Fraction
Koutroumpakis, E., Kaur, R., Taegtmeyer, H., & Deswal, A. M. (2021) · Heart Failure Clinics · doi:10.1016/j.hfc.2021.02.003 · Cited by 21
Selective deletion of endothelial mineralocorticoid receptor protects from vascular dysfunction in sodium-restricted female mice
Faulkner, J., Lluch, E., Kennard, S., Antonova, G. N., Jaffe, I. Z., & de Chantemèle, E. J. B. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00340-5 · Cited by 19
Female Gender Is Associated with Higher Susceptibility of Weight Induced Arterial Stiffening and Rise in Blood Pressure
Zuo, J., Chao, H., Tang, B., Avolio, A. P., Schlaich, M. P., Nolde, J. M., Adji, A. I., & Carnagarin, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163479 · Cited by 19
Underpinnings of Heart Failure With Preserved Ejection Fraction in Women - From Prevention to Improving Function. A Co-publication With the American Journal of Preventive Cardiology and the Journal of Cardiac Failure
RADAKRISHNAN, A., AGRAWAL, S., SINGH, N., Barbieri, A., Shaw, L. J., Gulati, M., & Lala, A. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.01.008 · Cited by 19
Glucosamine-Mediated Hexosamine Biosynthesis Pathway Activation Uses ATF4 to Promote “Exercise-Like” Angiogenesis and Perfusion Recovery in PAD
Alhusban, S., Nofal, M., Kovács‐Kása, A., Kress, T. C., Köseoğlu, M. M., Zaied, A. A., de Chantemèle, E. J. B., & Annex, B. H. (2024) · Circulation · doi:10.1161/circulationaha.124.069580 · Cited by 18
Renin-Angiotensin System - Past, Present and Future
Tolekova, A. N. (2017) · InTech eBooks · doi:10.5772/63179 · Cited by 18
Resistant Hypertension: Where are We Now and Where Do We Go from Here?
Pathan, M. K., & Cohen, D. L. (2020) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s223334 · Cited by 22
High body fat percentage is associated with primary aldosteronism: a cross-sectional study
Manosroi, W., & Atthakomol, P. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00654-w · Cited by 18
Pathophysiology of heart failure with preserved ejection fraction in overweight and obesity - Clinical and treatment implications
Rodrigues, M. M., & Falcão, L. M. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133182 · Cited by 18
Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease
Ostrominski, J. W., Harrington, J., Claggett, B. L., Filippatos, G. S., Desai, A. S., Jhund, P. S., Henderson, A. D., Lam, C. S. P., Senni, M., Shah, S. J., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.039 · Cited by 17
Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review
Wang, W., Wu, T.-H., Er, L., Huang, C., Tu, K., Fan, K., Tsai, C., Wang, S., Wu, C.-Y., Huang, S.-H., et al. (2024) · Hypertension Research · doi:10.1038/s41440-023-01538-x · Cited by 17
Unveiling Selected Influences on Chronic Kidney Disease Development and Progression
Fularski, P., Czarnik, W., Frankenstein, H., Gąsior, M., Młynarska, E., Rysz, J., & Franczyk, B. (2024) · Cells · doi:10.3390/cells13090751 · Cited by 19
Obesity-Associated Heart Failure as a Theoretical Target for Treatment With Mineralocorticoid Receptor Antagonists
Packer, M. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2090 · Cited by 17
Dietary sodium restriction sex specifically impairs endothelial function via mineralocorticoid receptor-dependent reduction in NO bioavailability in Balb/C mice
Faulkner, J., Harwood, D., Kennard, S., Antonova, G. N., Clere, N., & de Chantemèle, E. J. B. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00413.2020 · Cited by 17
The intersection of mineralocorticoid receptor activation and the FGF23–Klotho cascade: a duopoly that promotes renal and cardiovascular injury
Epstein, M., & Freundlich, M. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab254 · Cited by 17
Emerging Role of Leptin in Vascular and Placental Dysfunction in Preeclampsia
Elgazzaz, M., Brawley, A. M., Moronge, D., & Faulkner, J. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321676 · Cited by 16
Effect of the interaction between the visceral-to-subcutaneous fat ratio and aldosterone on cardiac function in patients with primary aldosteronism
Haze, T., Ozawa, M., Kawano, R., Haruna, A., Ohki, Y., Suzuki, S., Kobayashi, Y., Fujiwara, A., Saka, S., Tamura, K., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01170-9 · Cited by 16
Endocrine causes of hypertension: literature review and practical approach
de Fréminville, J.-B., Amar, L., Azizi, M., & Mallart-Riancho, J. (2023) · Hypertension Research · doi:10.1038/s41440-023-01461-1 · Cited by 17
Epicardial adipose tissue affects the efficacy of left atrial posterior wall isolation for persistent atrial fibrillation
Nakatani, Y., Sakamoto, T., Yamaguchi, Y., Tsujino, Y., & Kinugawa, K. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12359 · Cited by 15
Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension
Morimoto, S., & Ichihara, A. (2020) · Hypertension Research · doi:10.1038/s41440-020-0468-3 · Cited by 16
Significance of Discordant Results Between Confirmatory Tests in Diagnosis of Primary Aldosteronism
Fukumoto, T., Umakoshi, H., Ogata, M., Yokomoto‐Umakoshi, M., Matsuda, Y., Motoya, M., Nagata, H., Nakano, Y., Iwahashi, N., Kaneko, H., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa812 · Cited by 16
Do obesity and visceral adiposity promote heart failure with reduced ejection fraction?
Packer, M. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf645 · Cited by 21
Obesity Might Persistently Increase Adrenal Gland Volume: a Preliminary Study
Liu, F., Chen, Y., Xie, W., Liu, C., Zhu, Y., Tian, H., Ren, Y., & Chen, T. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04593-2 · Cited by 15
A Novel Mitochondrial Complex of Aldosterone Synthase, Steroidogenic Acute Regulatory Protein, and Tom22 Synthesizes Aldosterone in the Rat Heart
Bose, H. S., Whittal, R. M., Marshall, B., Rajapaksha, M., Wang, N., Bose, M., Perry, E. W., Zhao, Z., & Miller, W. L. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000365 · Cited by 16
The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism
Mao, Y., Zhao, K., Li, P., & Sheng, Y. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04562-6 · Cited by 14
Depot-specific adipose tissue modulation by SGLT2 inhibitors and GLP1 agonists mediates their cardioprotective effects in metabolic disease
Bakkar, N. Z., AlZaim, I., & EL‐Yazbi, A. F. (2022) · Clinical Science · doi:10.1042/cs20220404 · Cited by 19
Association of the ratio of visceral-to-subcutaneous fat volume with renal function among patients with primary aldosteronism
Haze, T., Hatakeyama, M., Komiya, S., Kawano, R., Ohki, Y., Suzuki, S., Kobayashi, Y., Fujiwara, A., Saka, S., Tamura, K., et al. (2021) · Hypertension Research · doi:10.1038/s41440-021-00719-w · Cited by 15
Perivascular Adipose Tissue in Vascular Function: Does Locally Synthesized Angiotensinogen Play a Role?
Cruz‐López, E. O., Uijl, E., & Danser, A. H. J. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001027 · Cited by 16
Early life stress exacerbates obesity in adult female mice via mineralocorticoid receptor-dependent increases in adipocyte triglyceride and glycerol content
Leachman, J. R., Cincinelli, C., Ahmed, N., Dalmasso, C., Xu, M., Gatineau, E., Nikolajczyk, B. S., Yiannikouris, F. B., Hinds, T. D., & Loria, A. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120718 · Cited by 15
Subclinical Primary Aldosteronism Is Characterized by Maladaptive Natriuretic Peptide and Adrenal Hormonal Physiology
Salle, S. P., Brown, J. M., Mahrokhian, S., Hanna, I., Honzel, B., Tsai, L. C., Newman, A. J., Wang, T. J., & Vaidya, A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf129 · Cited by 14
Paradoxical Increase of 24-Hour Urinary Aldosterone Levels in Obese Patients With Resistant Hypertension on a High Salt Diet
Dudenbostel, T., Li, P., & Calhoun, D. A. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa208 · Cited by 14
Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension
Jemtel, T. H. L., Richardson, W., Samson, R., Jaiswal, A., & Oparil, S. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0713-6 · Cited by 14
Cardiac dysfunction after preeclampsia; an overview of pro- and anti-fibrotic circulating effector molecules
Mohseni, Z., Derksen, E., Oben, J., Al‐Nasiry, S., Spaanderman, M. E. A., & Ghossein‐Doha, C. (2020) · Pregnancy Hypertension · doi:10.1016/j.preghy.2020.12.001 · Cited by 14
Aldosterone and mineralocorticoid receptor signaling as determinants of cardiovascular and renal injury: an extraordinary paradigm shift
Epstein, M. (2022) · Kidney International Supplements · doi:10.1016/j.kisu.2021.11.007 · Cited by 14
Regulation of the Renin-Angiotensin-Aldosterone System by Reactive Oxygen Species
Morato, M., Reina‐Couto, M., Pinho, D., Albino‐Teixeira, A., & Sousa, T. (2017) · InTech eBooks · doi:10.5772/67016 · Cited by 14
Subtype-specific Body Composition and Metabolic Risk in Patients With Primary Aldosteronism
Park, S. S., Ahn, C. H., Kim, S. W., Yoon, J. W., & Kim, J. H. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad520 · Cited by 13
Resistant hypertension: Renal denervation or intensified medical treatment?
Morganti, A., & Mancia, G. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.12.010 · Cited by 13
Maternal separation enhances anticontractile perivascular adipose tissue function in male rats on a high-fat diet
Loria, A. S., Spradley, F. T., Obi, I. E., Becker, B., Miguel, C. D., Speed, J. S., Pollock, D. M., & Pollock, J. S. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00197.2018 · Cited by 13
Serum leptin concentration can predict cardiovascular outcomes and all-cause death in maintenance hemodialysis patients
Qin, Z., Yang, Q., Yang, M., Han, M., Xiong, Y., Liao, R., & Su, B. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.06.003 · Cited by 13
Hypertension and human immunodeficiency virus: A paradigm for epithelial sodium channels?
Mutengo, K. H., Masenga, S. K., Mwesigwa, N., Patel, K. P., & Kirabo, A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.968184 · Cited by 14
Tracking Pathways Linking Obesity with Heart Failure
Manta, E., Iliakis, P., Fragoulis, C., Leontsinis, I., Stamoulopoulos, I., Chrysohoou, C. A., & Tsioufis, K. P. (2025) · Nutrients · doi:10.3390/nu17071250 · Cited by 17
Discontinuation and Reinitiation of Mineralocorticoid Receptor Antagonists in Patients with Heart Failure and Reduced Ejection Fraction
Landucci, L., Faxén, U. L., Benson, L., Dahlström, U., Carrero, J. J., Savarese, G., & Lund, L. H. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3523 · Cited by 12
Aldosterone stimulation mediates cardiac metabolism remodeling via Sirt1/AMPK signaling in canine model
Liu, G.-Z., Zhang, S., Li, Y., Liu, Y., Zhang, Y., Xin-bo, Z., Yuan, Y., Zhang, J.-W., Khannanova, Z., & Li, Y. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01641-2 · Cited by 12
Leptin-induced increase in blood pressure and markers of endothelial activation during pregnancy in Sprague Dawley rats is prevented by resibufogenin, a marinobufagenin antagonist
Hassan, M. J. M., Bakar, N. S., Aziz, M. A., Basah, N. K., & Singh, H. J. (2020) · Reproductive Biology · doi:10.1016/j.repbio.2020.03.004 · Cited by 12
Bariatric Surgery Induces a Differential Effect on Plasma Aldosterone in Comparison to Dietary Advice Alone
Berney, M., Vakilzadeh, N., Maillard, M. P., Faouzi, M., Grouzmann, E., Bonny, O., Favre, L., & Wuerzner, G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.745045 · Cited by 11

Authors: Huby, A.-C., Antonova, G., Groenendyk, J., Gomez-Sanchez, C. E., Bollag, W. B., Filosa, J. A., & de Chantemèle, E. J. B.
Affiliations: Augusta University (US)
From Physiology Department, Medical College of Georgia at Georgia Regents University, Augusta (A.-C.H., G.A., J.G., W.B.B., J.A.F., E.J.D.d.C.); Charlie Norwood VA Medical Center, Augusta, GA (W.B.B.); Endocrine Section, G.V. (Sonny) Montgomery VA Medical Center, and University of Mississippi Medical Center, Jackson (C..E.G.-S.).
ORCID: Bollag, Wendy B.
Filosa, Jessica A.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2015-12
Volume: 132
Issue: 22
Pages: 2134-2145
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.115.018226
OpenAlex: W2206025985
Cited by: 376
References: 49
Citations by year: 2026: 34 · 2025: 41 · 2024: 37 · 2023: 34 · 2022: 44 · 2021: 32 · 2020: 36 · 2019: 31 · 2018: 37 · 2017: 29 · 2016: 18 · 2015: 1
FWCI: 24.57
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: leptin, aldosterone secretion, CYP11B2, aldosterone synthase, obesity, hyperaldosteronism, adrenal glomerulosa cells, adipokines, endothelial dysfunction, myocardial fibrosis, calcium signaling, calcium/calmodulin-dependent protein kinase II, mineralocorticoid receptor, cardiovascular disease
MeSH terms: Adrenal Cortex, Aldosterone, Animals, Cells, Cultured, Endothelium, Vascular, Female, Fibrosis, Heart Diseases, Humans, Mice, Inbred C57BL, Mice, Obese, Rats, Inbred WKY, Rats, Zucker, Adipocytes, Mice, Knockout, Leptin, Cell Line, Tumor, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks